Literature DB >> 27504368

Predictors of Mortality in Paediatric Myocarditis.

Shahla Abrar1, Mohammed Junaid Ansari2, Mahima Mittal3, K P Kushwaha4.   

Abstract

INTRODUCTION: Paediatric myocarditis can present as mild flu like symptoms to fulminent form. Early identification of the severity of illness and prioritization of intensive care is helpful especially in developing countries with limited resources. AIM: To know the factors at admission that can predict mortality in paediatric myocarditis.
MATERIALS AND METHODS: This was an observational study which enrolled children who presented with fever of acute onset (less than 15 days in duration), and were diagnosed as suspected myocarditis on the basis of clinical features, Troponin I and echocardiography, according to Expanded criteria for myocarditis in Paediatric ward at our institute over a period from August 2014 to December 2015. Their clinical features, cardiac biomarkers and echocardiography findings were compared between survivors and non-survivors. STATISTICAL ANALYSIS: All statistical analysis was done using graphpad Prism 5 and SPSS statistical software. A Fisher exact p-value <0.05 was regarded as significant. Multivariate Logistic Regression was carried out to quantify the relationship between cardiac death and other predictor variables. The logistic coefficients for the predictor variables and their exponents, that is, log odds were calculated. Statistical significance of these predictor variables was interpreted by p-values.
RESULTS: A 17.7% (n=11/62) patients of paediatric myocarditis died in this study. New York Heart Association (NYHA) class IV dyspnea (p=0.0115) and hypotension (p=0.0174) were more in patients who did not survive. The mean value of Troponin I was more in the non-survivor group (0.958 ± 1.13ng/ml); (p=0.0074). More number of patients who died had Brain Natriuretic Peptide (BNP) levels increased in their plasma (p=0.0087) with higher mean value (p=0.0175). LV ejection fraction was decreased markedly in non survivor group with mean value of 37±8.09 % as compared to survivor group with mean value of 46.6±10.5%, (p=0.0115). On multivariate analysis, NYHA class IV dyspnea (p=0.0113), BNP (p=0.015) and ejection fraction (p = 0.0284) independently are the predictors of mortality in our study group.
CONCLUSION: Children with myocarditis having hypotension, raised Troponin I, BNP and decreased ejection fraction are more prone to die. NYHA IV dyspnea, higher levels of BNP and decreased EF are independently related to worst outcome.

Entities:  

Keywords:  Brain Natriuretic Peptide; Cardiac markers; Ejection fraction; Troponin I

Year:  2016        PMID: 27504368      PMCID: PMC4963728          DOI: 10.7860/JCDR/2016/19856.7967

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  33 in total

1.  Clinical problem-solving. One surprise after another.

Authors:  Nicholas J Leeper; Lianne S Wener; Gurpreet Dhaliwal; Sanjay Saint; Robert M Wachter
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

2.  Biomarkers in heart failure.

Authors:  Wei-Chung Chen; Kimberly D Tran; Alan S Maisel
Journal:  Heart       Date:  2010-02       Impact factor: 5.994

3.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

Review 4.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

5.  Recommendations for standardization of measurements from M-mode echocardiograms.

Authors:  J Roelandt; D G Gibson
Journal:  Eur Heart J       Date:  1980-10       Impact factor: 29.983

6.  Cardiac troponin T in patients with clinically suspected myocarditis.

Authors:  B Lauer; C Niederau; U Kühl; M Schannwell; M Pauschinger; B E Strauer; H P Schultheiss
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

7.  Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy.

Authors:  H J Why; B T Meany; P J Richardson; E G Olsen; N E Bowles; L Cunningham; C A Freeke; L C Archard
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

8.  Fulminant myocarditis treated with percutaneous cardiopulmonary support system (PCPS).

Authors:  Kiyohiro Oshima; Fumio Kunimoto; Hiroshi Hinohara; Yoshiro Hayashi; Junko Hirato; Yukio Tajima; Hiroyuki Kuwano
Journal:  Ann Thorac Cardiovasc Surg       Date:  2008-04       Impact factor: 1.520

9.  Gamma-globulin treatment of acute myocarditis in the pediatric population.

Authors:  N A Drucker; S D Colan; A B Lewis; A S Beiser; D L Wessel; M Takahashi; A L Baker; A R Perez-Atayde; J W Newburger
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

10.  Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Authors:  Torbjørn Omland; Marc S Sabatine; Kathleen A Jablonski; Madeline Murguia Rice; Judith Hsia; Ragnhild Wergeland; Sverre Landaas; Jean L Rouleau; Michael J Domanski; Christian Hall; Marc A Pfeffer; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2007-06-29       Impact factor: 24.094

View more
  9 in total

1.  Elevated Troponin in the First 72 h of Hospitalization for Pediatric Viral Myocarditis is Associated with ECMO: An Analysis of the PHIS+ Database.

Authors:  Arene Butto; Joseph W Rossano; Deipanjan Nandi; Chitra Ravishankar; Kimberly Y Lin; Matthew J O'Connor; Robert E Shaddy; Pirouz Shamszad
Journal:  Pediatr Cardiol       Date:  2018-04-13       Impact factor: 1.655

2.  Correspondence: Predictors of Mortality in Paediatric Myocarditis.

Authors:  Anirban Mandal; Amitabh Singh; Puneet Kaur Sahi; Bhavika Rishi
Journal:  J Clin Diagn Res       Date:  2017-03-01

3.  Immune Checkpoint Inhibitor-Associated Myocarditis.

Authors:  Sarju Ganatra; Tomas G Neilan
Journal:  Oncologist       Date:  2018-05-25

4.  A Risk Prediction Model for In-hospital Mortality in Patients with Suspected Myocarditis.

Authors:  Duo Xu; Ruo-Chi Zhao; Wen-Hui Gao; Han-Bin Cui
Journal:  Chin Med J (Engl)       Date:  2017-04-05       Impact factor: 2.628

5.  Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis.

Authors:  Yi-Jung Chang; Hsiang-Ju Hsiao; Shao-Hsuan Hsia; Jainn-Jim Lin; Mao-Sheng Hwang; Hung-Tao Chung; Chyi-Liang Chen; Yhu-Chering Huang; Ming-Han Tsai
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

6.  Prognosis Implication of N-Terminal Pro-B-Type Natriuretic Peptide in Adult Patients With Acute Myocarditis.

Authors:  Yan Zhao; Naqiang Lyu; Wei Zhang; Huiqiong Tan; Qi Jin; Aimin Dang
Journal:  Front Cardiovasc Med       Date:  2022-03-30

Review 7.  Parametric Mapping Cardiac Magnetic Resonance Imaging for the Diagnosis of Myocarditis in Children in the Era of COVID-19 and MIS-C.

Authors:  Bibhuti B Das; Jyothsna Akam-Venkata; Mubeena Abdulkarim; Tarique Hussain
Journal:  Children (Basel)       Date:  2022-07-16

8.  Findings and Outcome of Transcatheter Right Ventricular Endomyocardial Biopsy and Hemodynamic Assessment in Children with Suspected Myocarditis or Cardiomyopathy.

Authors:  Alessia Callegari; Daniel Quandt; Achim Schmitz; Karin Klingel; Christian Balmer; Hitendu Dave; Oliver Kretschmar; Walter Knirsch
Journal:  Int J Environ Res Public Health       Date:  2022-08-21       Impact factor: 4.614

Review 9.  The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis.

Authors:  Aleksey Chauin
Journal:  Vasc Health Risk Manag       Date:  2021-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.